long term risks of semaglutide GLP-1 drugs such as and tirzepatide are transforming obesity and diabetes care in India, but experts warn that improper use could lead to significant muscle loss. A new India-specific consensus highlights New Report Showing Weight Loss

Injectable Semaglutide (Wegovy) Clinical trials showed approximately 15 percent average weight loss over 68 weeks compared with placebo

Faster and More Complete Recovery When your body has better blood flow and less inflammation, healing happens more effectively

Fukami K, Yamagishi S, Sakai K, Kaida Y, Minami A, Nakayama Y, et al

What b12 injections does not do: it does not replace surgical correction in patients who genuinely need a surgical solution, it does not stop the underlying aging cascade (collagen loss, bone resorption, fat pad descent, hormonal shifts in perimenopause), and it does not work identically on every Fitzpatrick skin type